FDA Approves Tekturna HCT® as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

FDA Approves Tekturna HCT® as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

Jul 21, 2009
Source URL: https://prod1.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0

List of links present in page
  1. https://prod1.novartis.com/us-en/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0